SAM
RETA

Serengeti Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Serengeti Asset Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
2021
Q3 		$1.51M Buy
2021
Q2 		– Sell
2021
Q1 		$2.49M Hold
2020
Q4 		$3.09M Sell
2020
Q3 		$2.73M Buy
2020
Q2 		$780K Sell
2020
Q1 		$2.17M Buy